Pathogenesis of avian bornavirus in experimentally infected cockatiels.
PPD is caused by a nonpurulent inflammation of the autonomic nervous system of the upper gastrointestinal tract, the peripheral and central nervous tissue, and the cardiac conduction system (5,6). Gastrointestinal and neurologic signs can appear alone or in combination (4,7,8). The clinical signs are nonspecific, and PDD can be definitively diagnosed only by pathohistologic detection of lymphoplasmacytic infiltrates of ganglia in the upper gastrointestinal tract. However, a negative finding cannot exclude the presence of PDD (4,6,8,9).
In 2008, 2 independent groups of research scientists described a new virus, avian bornavirus (ABV), which was amplified from samples from PDD-affected birds. Since then, 6 different ABV genotypes have been detected in psittacines birds. Additional genotypes have been detected in a canary (Serinus canaria), wild Canada geese (Branta canadensis), and trumpeter swans (Cygnus buccinator) (3,10-12). Recent studies substantiate the crucial role of ABV as the etiologic agent for PDD (10,11). Several scientific groups found ABV in 60%-100% of PDD-affected birds studied (10,11,13-15). Surveillance studies in aviaries showed that not all birds were affected after exposure to PDD-diseased and ABV-positive birds, and clinical signs and infection status varied considerably in birds that were affected. In addition, some ABV-positive birds showed no clinical signs (16-20). These facts indicate that host factors as well as features of the infectious agent, ABV, play a key role for disease induction (18).
Initial studies of experimental infections in birds fulfilled Henle-Koch postulates by using small numbers of animals. Gancz et al. (21) inoculated 3 cockatiels by multiple routes with brain homogenate containing ABV4. Sixty-six days postinoculation (dpi), PDD-associated signs, including characteristic histopathologic lesions, developed in 2 of the 3 birds, and test results were positive for ABV-4. The implications of these findings were obscured by the fact that the brain homogenate also included sequences with partial analogy to viruses of the family Astroviridae and family Retroviridae. After inoculating 4-day-old mallards (Anas platyrhynchos; n = 15) with ABV-4, Gray and colleagues (22) detected ABV RNA in the feces and antibodies against ABV in serum, but they did not detect any clinical signs or PDD-associated lesions. Later, Gray et al. (23) inoculated 2 adult Patagonian conures (Cyanoliseus patagonis) with ABV-4. The conures were known to be chronic carriers of psittacine herpesvirus, but they appeared to be healthy. Antibodies against ABV were detected 33 dpi, and shedding of viral RNA was detected 62 dpi. Clinical PDD signs developed in both birds, after which 1 bird died and the other was euthanized. Histopathologic analysis showed typical PDD lesions. It was not determined whether the herpesvirus infection was a potentiating factor (21-23).
Reliable studies that include sufficient numbers of animals to address the host variability over an adequate investigation period are needed to clarify the pathogenetic effects of ABV infection on the development of PDD. More precisely, this implies the need for investigating the course of clinical signs, seroconversion, histopathologic lesions, and virus shedding and distribution in the tissues of affected birds. To further the understanding of ABV and the associated disease, we infected 18 cockatiels with ABV by using 2 different inoculation routes and monitored them for 33 weeks. Our findings show that a persistent ABV infection was induced by in all 18 birds and that it was possible to reliably reproduce all of the known natural ABV disease patterns.
Material and Methods
Inoculum and Sequencing
The virus for inoculation was originally isolated from the brain of a scarlet macaw (Ara macao) that died from PDD; the inoculation was passaged 6 times in the quail cell line CEC-32 (24). The persistently ABV-infected CEC-32 cells were suspended in medium with 2% fetal bovine serum, sonicated, clarified by centrifugation at 3,000 x g for 10 min, and assayed to determine infectivity. For inoculations, we used an infectivity titer of 104 50% infectious dose/mL.
By using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions, we isolated total RNA for sequencing from 200 [micro]L of virus-containing supernatant. Total RNA was reverse transcribed by using random hexamer primers. PCR for parts of the large viral polymerase and the nucleocapsid protein genes of avian bornavirus was performed as described (11). We analyzed PCR products by using gel electrophoresis and purified the products for sequencing by using the QIAquick PCR Purification Kit (QIAGEN). Sequencing was carried out by LGC Genomics (Berlin), and BlastN (http://blast. ncbi.nlm.nih.gov/Blast.cgi) was used to align generated sequence information.
Experimental Infection of Cockatiels
For inoculation purposes, we divided the cockatiels into 2 groups (groups ic and iv), each consisting of 9 animals. We intracerebrally (IC) inoculated birds in group ic and intravenously (IV) inoculated birds in group iv with 0.1 mL of the inoculum described above. All birds were under isoflurane anesthesia when inoculated. One bird remained untreated and served as a sentinel bird in group ic. Another group of 9 birds from the same flock served as controls; they remained untreated and were kept separate from the inoculated birds during the investigation period.
Study Design (Sampling, Clinical Investigations, and Necropsies)
Over a period of 230 days, we surveyed the birds daily to determine their health status. We obtained swab samples from the crop and cloaca to test for the presence of ABV RNA by using real-time reverse transcription PCR as described (10). Cycle thresholds ([C.sub.t]) >36.0 were considered negative (10). Swab samples were obtained every other day until all birds of the respective group had ABV-positive test results, then specimens were obtained weekly. In parallel, once a week we obtained 0.3-mL blood samples for indirect immunofluorescence assay (IIFA) detection of antibodies against ABV, as described (25). For humane reasons, we euthanized birds with clinical signs typical of PDD (emaciation, undigested seed in the feces, neurologic signs) and reduced general condition. All remaining birds, including control birds, were euthanized 115 or 116 dpi or at the end of the trial (229 or 230 dpi).
We obtained samples of brain, eye, spinal cord, ischiadic nerve, adrenal gland, heart, liver, kidney, spleen, pancreas, crop, proventriculus, gizzard, intestine, pectoral muscle, and skin with feathers from all birds that died or were euthanized. For histopathologic analysis immunohistochemical testing, and other immunohistologic procedures, samples were fixed in 5% buffered formalin, embedded in paraffin wax, and used for preparation of 5-um sections stained with hematoxylin and eosin. Samples from similar organs were frozen fresh for subsequent real-time PCR to detect ABV RNA. In addition, infectious virus was isolated by using samples from brain and retina as described (25). To exclude the presence of any other infection, we examined samples of blood, liver, and lung for bacteria; we used mycological staining to examine samples of proventriculus for infection with yeast; and we examined samples from all intestinal parts for parasites.
Indirect Immunofluorescence Assay
Antibodies against ABV were detected by use of an IIFA on persistently Borna disease virus (BDV)-infected Madin-Darby canine kidney cells. For the assay, we used a 1:50 dilution of fluorescein isothiocyanate-conjugated goat anti-bird IgG (Bethyl Laboratories, Inc., Montgomery, TX, USA), as described (25).
We performed immunohistochemical testing according to the avidin-biotin complex method, as described (25,26). This method uses a polyclonal rabbit antibody directed against the phosphoprotein and the X protein of BDV.
For virus isolation, we performed infectivity assays as described by Narayan et al. (27) and Herzog et al. (25). Organ samples were homogenized, and 10-fold dilutions were prepared in GIBCO Glasgow Minimum Essential Medium BHK-21 1x (Invitrogen, Paisley, UK) with 10% fetal bovine serum. The mixture was then mixed with equal volumes of freshly dispersed cells of the quail cell line CEC32 and then incubated on Lab-Tek Chamber Slides (Nunc, Roskilde, Denmark) for 6 days at 37[degrees]C. Virus replication was demonstrated by indirect immunofluorescence by using polyclonal serum specimens, which cross-reacted reliably with ABV antigen, from rats experimentally infected with BDV (25).
We used the Wilcoxon-Mann-Whitney-test to ascertain differences between the IC- and IV-inoculated groups. U <11 (critical value with [alpha] = 0.005) was considered highly significant for calculated test statistics.
We used BlastN (http://blast.ncbi.nlm.nih.gov/Blast. cgi) to compare newly generated sequences of parts of the nucleocapsid protein and large viral polymerase genes with sequences available from GenBank. Both genes showed highest accordance (99%) with ABV genotype 4 (EU781959.1 and FJ002323.1).
During the 230-day investigation period, 5 of the 18 inoculated birds (3 from group iv and 2 from group ic) showed clinical signs typical of PDD: birds iv1 and iv3 had gastrointestinal signs, birds ic1 and iv5 showed neurologic signs, and bird ic2 had gastrointestinal and neurologic signs. In bird ic2, the following signs developed 33, 37, and 41 dpi, respectively: general symptoms, e.g., apathy; undigested seeds in the feces; and epileptic-like seizures. In birds iv3 and iv2, gastrointestinal signs first became obvious 116 and 126 dpi, respectively. In birds iv5 and ic1, which were only affected neurologically, signs were first noticed 159 and 199 dpi, respectively.
In addition, birds ic6 and iv2 died suddenly and unexpectedly, without obvious signs, 66 and 120 dpi, respectively. Three apparently healthy birds from each group (birds iv3, iv4, iv7, ic3, ic4, and ic8) were euthanized 115 or 116 dpi. At the end of the investigation period, 229 or 230 dpi, the remaining birds (iv1, iv5, iv8, iv9, ic5, ic7, and ic9) and the sentinel bird (se1), which all appeared clinically healthy, were euthanized (Table 1). The control birds were in a good health status during the entire investigation period and were euthanized with the other birds after 230 days.
Gross Findings and Histopathologic Lesions
Necropsy revealed a dilated proventriculus in 7 of the 18 inoculated birds (ic1, ic2, ic3, iv1, iv2, iv3, and iv4), 4 of which had shown signs typical of PDD (Table 2). Dilatation of the proventriculus was most severe in bird ic2, which had both gastrointestinal and neurologic signs. No macroscopic alterations were detected in the remaining 11 inoculated birds, the sentinel bird, or the 9 control birds.
Histopathologic examination revealed that all infected birds and the sentinel bird had mononuclear infiltrates characteristic of PDD in a wide range of organs and of considerable severity. Most of the immune cell infiltrates were in the central nervous system and the gastrointestinal tract, but they were also present in heart; liver; kidney; pancreas; skin with feathers; and, in 1 case, the spleen. In some of the animals, the infiltrates had a follicle-like appearance. Infiltrates were not detected in the pectoral muscle of any birds. No other infections were detected during bacteriologic, mycologic, and parasitologic examinations. The control group did not have histopathologic alterations in organs and did not have any other infection.
Detection of ABV RNA and Antibody against ABV
We detected ABV RNA in swab specimens from all inoculated birds and the sentinel bird. We obtained the first positive test results for group ic 19-29 dpi, whereas we first amplified ABV RNA from group iv samples 25-72 dpi (Figure 1). By using the Wilcoxon-Mann-Whitney test, we determined that ABV RNA was detected significantly earlier in group ic than in group iv (calculated value for test statistic U = 5.5, which is <11 [critical value with [n.sub.1] = 9 and [n.sub.2] = 9] and therefore considered to be highly significant, with [alpha] = 0.005). We obtained the first positive ABV RNA test results for the sentinel bird 76 dpi (Figure 1). The [C.sub.t] for all birds constantly decreased during the trial, from 35.6 at first ABV RNA detection to 19.8 at last sampling (geometric mean values).
Antibodies against ABV were first detected in group ic 7-63 dpi, and group iv birds seroconverted 29-57 dpi (Figure 2). Statistical analysis did not show any noticeable difference between the ic and iv group (calculated value for test statistic U = 39.5, which is >21 [critical value with [n.sub.1] = 9 and [n.sub.2] = 9] and thus considered not significant, with [alpha] = 0.05). Antibody titers in groups ic and iv steadily increased to [less than or equal to] 20,480 during the investigation period (Figure 3). We did not detect ABV RNA or antibodies against ABV in control group birds during the investigation period.
Detection of ABV RNA in Organs
We detected ABV RNA in all organs that were examined 115 or 116 dpi and 229 or 230 dpi. A high amount of ABV RNA (geometric mean [C.sub.t] 12.0-17.0) was found in the central nervous system, gastrointestinal tract, and in skin with feathers. Moderate amounts of ABV RNA (geometric mean [C.sub.t] 17.0-23.0) were found in heart, kidney, spleen, and pancreas. The lowest amounts of ABV RNA (geometric mean [C.sub.t] 23.0-29.0) were found in pectoral muscle and liver. In the sentinel bird, only skin with feathers had positive test results ([C.sub.t] 28.77), but brain, crop, gizzard, and intestine had high [C.sub.t] (>36.0); all other organs remained negative for ABV RNA (Figure 4). We did not detect ABV RNA in the organs of control birds.
The detection of viral phosphoprotein and X-protein was mostly restricted to the central nervous system and the heart. In some cases, ABV antigen was also found in some parts of the gastrointestinal tract. We detected X-protein in all group ic birds but not in the sentinel bird. We could not detect phosphoprotein p24 in bird iv3 or in the sentinel bird. ABV antigen was not found in any of the organs of the control birds.
We isolated infectious ABV from all inoculated birds. No infectious virus was detected from the organs of the sentinel bird or birds in the control group.
PPD was first described in the late 1970s, but its etiology remained unknown until 2008 when ABV and its correlation to PDD were discovered. Numerous studies using naturally infected animals followed this discovery and substantiated the close association between ABV infection and PDD. This association has been further confirmed by several experimental trials (21-23,28) that used various bird species. However, detailed information about the occurrence of clinical signs, seroconversion, histologic lesions, viral RNA, and infectious virus using a statistically adequate group and sample size was still lacking. We reliably and successfully demonstrated these details in our study. We reproduced the natural pattern of ABV disease variation and the typical signs. We also achieved an infection rate of 100%, with the development of a persistent ABV infection in all animals, as indicated by the constant presence of ABV RNA, ABV antigen, infectious virus, and serum antibodies. These results are in agreement with other experimental data (21) and with infection in birds with natural PDD (18-20,28).
In our experiments, the discrepancies in infection status and in the development of clinical signs in infected but clinically healthy birds could be a result of several host factors (e.g., age, immune status), virulence, and adaption of the inoculated ABV suspension to the cell culture. These variations have already been described for mammalian BDV infections (29-32). The cockatiels most likely had considerable variability in their genetic makeup, in contrast, for example, with inbred strains of laboratory mice. Such genetic variability could have a substantial effect on disease susceptibility. Bird ic2 did show a severe progression of clinical signs, and clinical signs developed in 4 other cockatiels. This variability in the course of ABV infection and development of PDD is similar to the variability observed in natural cases of ABV infection (33).
ABV RNA and antibodies to ABV were detected in all inoculated birds, and titers of antibody against ABV steadily increased during the investigation period; however, these antibodies did not influence the outcome of clinical disease. Payne et al. (28) also reported on ABV-infected cockatiels in which antibodies to ABV did not influence the outcome of clinical disease. Narayan et al. (27) similarly reported that in mammals with Borna disease, antibodies against ABV do not exhibit protective properties and seem not to play a role in immunopathogenesis. Thus, detection of antibodies to ABV does not indicate antiviral immunity; on the contrary, they indicate a resolved or ongoing ABV infection with possible risk for the development of PDD. The relevance of these findings should be considered in the diagnosis of possible ABV infections.
We detected ABV RNA considerably earlier in group ic than in group iv. This finding agrees with results of studies in which rats were experimentally infected with BDV and in which the IC route was shown to be the most efficient route for reproducing the disease; however, it was never possible in those studies to infect rats with BDV by iv inoculation (27,34). Therefore, the successful infection of cockatiels with ABV by IV inoculation represents a notable difference between ABV and BDV infection. This difference is highlighted by similarities in the postinoculation timing of seroconversion and the appearance of clinical signs in bird groups iv and ic.
Gastrointestinal as well as neurologic signs could be noted in some birds of both groups. Moreover, we detected infectious virus and ABV RNA in all organs of all infected birds, whereas BDV exhibits strict neurotropism in immune-competent mammals, and spread of the virus to peripheral organs is only possible in immune-incompetent mammals (30,35). Whether this is also the case for ABV infection remains unclear. However, in our studies, ABV RNA was constantly present at the highest levels in the central nervous system and gastrointestinal tract, indicating that ABV also has an affinity for central and peripheral nervous tissue, as previously described (13,18,20,21,36). Additional investigations are warranted to resolve this issue.
Antibodies to ABV did not develop in the sentinel bird (se1) during the investigation period; however, increasing amounts of ABV RNA were detected in swab samples from the bird beginnning 76 dpi. After Se1 was euthanized, ABV RNA was amplified from the bird's skin with feathers but not from other organs. The presence of ABV RNA in skin with feathers might be a result of contamination by virus that was constantly shed from other birds in the same cage. In contrast, se1 did show lymphoplasmacytic infiltrates typical for PDD in brain, heart, intestine, or liver. These findings indicate that bird se1 reacted differently than the experimentally infected birds, and it may have been more efficient than the experimental cohort in combatting the infection. This might be a result of infection by a different route, such as the oral or intranasal route. Additional investigations are needed to characterize the effects of different infection routes on the outcome of ABV infection and the development of PDD. It is already known from BDV infection of rats that the route of infection determines the severity of disease and that an early up-regulation of BDV-specific CD4 T cells can efficiently protect against infection by the virus (37).
In summary, the experimental infection of cockatiels in this study provides reliable evidence that ABV can induce a persistent infection by various routes and lead to disease patterns similar to those in natural infection. Moreover, the etiologic role of ABV for the development of PDD was further confirmed in an adequately sized cohort of cockatiels. Our detailed investigation of clinical signs, seroconversion, histopathologic lesions, and various viral parameters allowed us to document essential data on the course and clinical outcome of ABV infections and on the similarities and differences between ABV and BDV infections. This will serve as a basis for further investigations on the underlying pathogenesis and the main contributing virus and host factors in ABV infection. It remains to be determined whether immunopathologic mechanisms that are based on a T cell-mediated immune reaction, as known for BDV infection, play a role in ABV infection and the development of PDD. Findings in the present study add to our understanding of the pathogenesis of ABV infection and will facilitate interpretation of clinical findings. Antibodies to ABV do not indicate immunity; instead, they point toward a resolved or ongoing ABV infection and a possible risk for the development of PDD.
We thank Kristina Maier for help with sampling and surveying of the birds and Philipp Olias for his advice.
The Loro Parque Fundacion provided financial support for the study (project identification: PP-65-2009-1).
Mrs Piepenbring is a veterinarian at the Clinic for Birds, Reptiles, Amphibians and Fish, Justus-Liebig University, Giessen, Germany, where she is also a member of the PDD/ABV Working Group Her research interests are avian and reptile medicine and avian virology.
(1.) Daoust PY, Julian RJ, Yason CV, Artsob H. Proventricular impaction associated with nonsuppurative encephalomyelitis and ganglioneuritis in two Canada geese. J Wildl Dis. 1991;27:513-7.
(2.) Perpinan D, Fernandez-Bellon H, Lopez C, Ramis A. Lymphoplasmacytic myenteric, subepicardial, and pulmonary ganglioneuritis in four nonpsittacine birds. J Avian Med Surg. 2007;21:210-4. http://dx.doi.org/10.1647/1082-6742(2007)21[210: LMSAPG]2.0.CO;2
(3.) Weissenbock H, Sekulin K, Bakonyi T, Hogler S, Nowotny N. Novel avian Bornavirus in a nonpsittacine species (Canary; Serinus canaria) with enteric ganglioneuritis and encephalitis. J Virol. 2009;83:11367-71. http://dx.doi.org/10.1128/JVI.01343-09
(4.) Gregory CR. Proventricular dilatation disease. In: Ritchie BW, editor. Avian viruses, function and control. Lake Worth (FL): Wingers Publishing Inc; 1995. p. 439-48.
(5.) Dahlhausen B, Aldred S. Resolution of clinical proventricular dilatation disease by cycloogenase 2 inhibition. In: Proceedings of the 23rd Annual Conference and Expo of the Association of Avian Veterinarians, Monterey, CA, USA, Aug 26-30, 2002. Denver (CO): The Association; 2002. p. 9-12.
(6.) Lierz M. Proventricular dilatation disease. In: Harcourt-Brown N, Chitty J, editors. BSAVA manual of psittacine birds. 2nd ed. Gloucester (UK): British Small Animal Veterinary Association; 2005. p. 161-2.
(7.) Berhane Y, Smith DA, Newman S, Taylor M, Nagy E, Binnington B, et al. Peripheral neuritis in psittacine birds with proventricular dilatation disease. Avian Pathol. 2001;30:563-70. http://dx.doi. org/10.1080/03079450120078770
(8.) Lublin A, Mechani S, Farnoushi I, Perl S, Bendheim U. An outbreak of proventricular dilatation disease in psittacine breeding farm in Israel. Israel Journal of Veterinary Medicine. 2006;61:16-9.
(9.) Gregory CR, Latimer KS, Campagnoli RP, Ritchie BW. Histologic evaluation of the crop for diagnosis of proventricular dilatation syndrome in psittacine birds. J Vet Diagn Invest. 1996;8:76-80. http://dx.doi.org/10.1177/104063879600800112
(10.) Honkavuori KS, Shivaprasad HL, Williams BL, Quan PL, Hornig M, Street C, et al. Novel borna virus in psittacine birds with proventricular dilatation disease. Emerg Infect Dis. 2008;14:18836. http://dx.doi.org/10.3201/eid1412.080984
(11.) Kistler AL, Gancz A, Clubb S, Skewes-Cox P, Fischer K, Sorber K, et al. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. Virol J. 2008;5:88. http://dx.doi.org/10.1186/1743-422X-5-88
(12.) Delnatte P, Berkvens C, Kummrow M, Smith DA, Campbell D, Crawshaw G, et al. New genotype of avian bornavirus in wild geese and trumpeter swans in Canada. Vet Rec. 2011;169:108. http:// dx.doi.org/10.1136/vr.d4620
(13.) Ouyang N, Storts R, Tian Y, Wigle W, Villanueva I, Mirhosseini N, et al. Histopathology and the detection of avian bornavirus in the nervous system of birds diagnosed with proventricular dilatation disease. Avian Pathol. 2009;38:393-401. http://dx.doi. org/10.1080/03079450903191036
(14.) Rinder M, Ackermann A, Kempf H, Kaspers B, Korbel R, Staeheli P. Broad tissue and cell tropism of avian bornavirus in parrots with proventricular dilatation disease. J Virol. 2009;83:5401-7. http:// dx.doi.org/10.1128/JVI.00133-09
(15.) Weissenbock H, Bakonyi T, Sekulin K, Ehrensperger F, Doneley RJ, Durrwald R, et al. Avian bornaviruses in psittacine birds from Europe and Australia with proventricular dilatation disease. Emerg Infect Dis. 2009;15:1453-9. http://dx.doi.org/10.3201/eid1509.090353
(16.) De Kloet SR, Dorrestein GM. Presence of avian bornavirus RNA and anti-avian bornavirus antibodies in apparently healthy macaws. Avian Dis. 2009;53:568-73. http://dx.doi.org/10.1637/8828040209-Reg.1
(17.) Heffels-Redmann U, Enderlein D, Herzog S, Herden C, Piepenbring A, Neumann D, et al. Occurrence of avian bornavirus infection in captive psittacines in various European countries and its association to proventricular dilation disease. Avian Pathol. 2011;40:419-26. http://dx.doi.org/10.1080/03079457.2011.589825
(18.) Lierz M, Hafez HM, Honkavuori KS, Gruber AD, Olias P, Abdelwhab EM, et al. Anatomical distribution of avian bornavirus in parrots, its occurrence in clinically healthy birds and ABV antibody detection. Avian Pathol. 2009;38:491-6. http://dx.doi. org/10.1080/03079450903349238
(19.) Kistler AL, Smith JM, Greninger AL, Derisi JL, Ganem D. Analysis of naturally occurring avian bornavirus infection and transmission during an outbreak of proventricular dilatation disease among captive psittacine birds. J Virol. 2010;84:2176-9. http://dx.doi. org/10.1128/JVI.02191-09
(20.) Villanueva I, Gray P, Mirhosseini N, Payne S, Hoppes S, Honkavuori KS, et al. The diagnosis of proventricular dilatation disease: use of a Western blot assay to detect antibodies against avian borna virus. Vet Microbiol. 2010;143:196-201. http://dx.doi.org/10.1016/j. vetmic.2009.11.041
(21.) Gancz AY, Kistler AL, Greninger AL, Farnoushi Y, Mechani S, Perl S, et al. Experimental induction of proventricular dilatation disease in cockatiels (Nymphicus hollandicus) inoculated with brain homogenates containing avian bornavirus 4. Virol J. 2009;6:100. http://dx.doi.org/10.1186/1743-422X-6-100
(22.) Gray PL, Villanueva I, Mirhosseini N, Hoppes S, Payne S, Tizard I. Experimental infection of birds with avian bornavirus. In: Proceedings of the Association of Avian Veterinarians 30th annual conference and expo, Milwaukee, WI, 2009, Aug 10-13, 2009. Denver (CO): The Association; 2009. p. 7-8.
(23.) Gray P, Hoppes S, Suchodolski P, Mirhosseini N, Payne S, Villanueva I, et al. Use of avian bornavirus isolates to induce proventricular dilatation disease in conures. Emerg Infect Dis. 2010;16:473-9. http://dx.doi.org/10.3201/eid1603.091257
(24.) Zoller B, Redman-Muller I, Nanda I, Guttenbach M, Dosch E, Schmid M, et al. Sequence comparison of avian interferon regulatory factors and identification of the avian CEC-32 cell as a quail cell line. J Interferon Cytokine Res. 2000;20:711-7. http:// dx.doi.org/10.1089/10799900050116417
(25.) Herzog S, Enderlein D, Heffels-Redmann U, Piepenbring A, Neumann D, Kaleta EF, et al. Indirect immunofluorescence assay for intra vitam diagnosis of avian bornavirus infection in psittacine birds. J Clin Microbiol. 2010;48:2282-4. http://dx.doi.org/10.1128/ JCM.00145-10
(26.) Herden C, Herzog S, Wehner T, Zink C, Richt J, Frese K. Comparison of different methods of diagnosing Borna disease in horses post mortem. In: Wernery U, Wade J, Mumford JA, Kaaden JR, editors. Equine infectious diseases VIII. Newmarket (UK): R&W Publications; 1999. p. 286-90.
(27.) Narayan O, Herzog S, Frese K, Scheefers H, Rott R. Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J Infect Dis. 1983;148:305-15. http://dx.doi. org/10.1093/infdis/148.2.305
(28.) Payne S, Shivaprasad HL, Mirhosseini N, Gray P, Hoppes S, Weissenbock H, et al. Unusual and severe lesions of proventricular dilatation disease in cockatiels (Nymphicus hollandicus) acting as healthy carriers of avian bornavirus (ABV) and subsequently infected with a virulent strain of ABV. Avian Pathol. 2011;40:15-22. http://dx.doi.org/10.1080/03079457.2010.536978
(29.) Richt JA, Pfeuffer I, Christ M, Frese K, Bechter K, Herzog S. Borna disease virus infection in animals and humans. Emerg Infect Dis. 1997;3:343-52. http://dx.doi.org/10.3201/eid0303.970311
(30.) Rott R, Becht H. Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol. 1995;190:17-30. http://dx.doi. org/10.1007/978-3-642-78618-1_2
(31.) Herzog S, Frese K, Rott R. Studies on the genetic control of resistance of black hooded rats to Borna disease. J Gen Virol. 1991;72:535-40. http://dx.doi.org/10.1099/0022-1317-72-3-535
(32.) Herzog S, Kompter C, Frese K, Rott R. Replication of Borna disease virus in rats: age-dependent differences in tissue distribution. Med Microbiol Immunol (Berl). 1984;173:171-7. http://dx.doi. org/10.1007/BF02122108
(33.) Heffels-Redmann U, Enderlein D, Herzog S, Piepenbring A, Burkle M, Neumann D, et al. Follow-up investigations on different courses of natural avian bornavirus infections in psittacines. Avian Dis. 2011. In press.
(34.) Richt JA, VandeWoude S, Zink MC, Clements JE, Herzog S, Stitz L, et al. Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin Infect Dis. 1992;14:1240-50. http://dx.doi.org/10.1093/clinids/14.6.1240
(35.) Richt J, Herzog S, Grabner A, Garten W, Herden C. Borna disease in equines. In: Sellon DC, Long M, editors. Equine infectious diseases. St. Louis (MO): Elsevier; 2007. p. 201-16.
(36.) Enderlein D, Herzog S, Herden C, Neumann D, Briese T, Kaleta EF, et al. Avian bornavirus: detection of antibodies and RNA in PDD-affected birds [in German]. In: Krautwald-Junghanns ME, Kaleta EF, editors. First conference on diseases of birds and reptiles of the German Veterinary Medical Society; Giessen, Germany, Sept 2527, 2009. Leipzig (Germany): The Society; 2009. p. 18-20.
(37.) Richt JA, Schmeel A, Frese K, Carbone KM, Narayan O, Rott R. Borna disease virus-specific T cells protect against or cause immunopathological Borna disease. J Exp Med. 1994;179:1467-73. http://dx.doi.org/10.1084/jem.179.5.1467
Author affiliation: Justus Liebig University Giessen, Giessen, Germany
Address for correspondence: Anne K. Piepenbring, Clinic for Birds, Reptiles, Amphibians and Fish, Faculty of Veterinary Medicine, Justus-Liebig University Giessen, Frankfurter StraBe 91-93, 35392 Giessen, Germany; email: firstname.lastname@example.org
Table 1. Premortem findings in cockatiels experimentally infected with ABV * Antibodies against ABV Age at RNA ([double inoculation, First Titer dagger]), first Bird d/sex detected, dpi ([dagger]) detected, dpi ic1 137/F 43 160 27 ic2 121/F 29 20 21 ic3 137/F 35 320 25 ic4 137/F 7 20 19 ic5 121/F 57 320 29 ic6 137/M 43 1,280 25 ic7 137/M 63 160 29 ic8 137/F 43 640 27 ic9 44/M 7 10 25 iv1 137/F 57 320 71 iv2 137/F 35 160 35 iv3 137/M 57 640 43 iv4 137/M 29 40 63 iv5 121/F 35 640 72 iv6 121/F 43 640 33 iv7 137/M 35 40 35 iv8 137/M 35 40 43 iv9 44/F 29 40 25 se1 137/M NA -- 76 Gastrointestinal signs Neurologic signs First Titer First Titer Bird detected, dpi ([dagger]) detected, dpi ([dagger]) ic1 -- -- 199 5,120 ic2 37 320 41 320 ic3 -- -- -- -- ic4 -- -- -- -- ic5 -- -- -- -- ic6 -- -- -- -- ic7 -- -- -- -- ic8 -- -- -- -- ic9 -- -- -- -- iv1 126 5,120 -- -- iv2 -- -- -- iv3 116 10,240 -- -- iv4 -- -- -- -- iv5 -- -- 159 5,120 iv6 -- -- -- -- iv7 -- -- -- -- iv8 -- -- -- -- iv9 -- -- -- -- se1 -- -- -- -- Died, Euthanized, Bird dpi dpi ic1 -- 206 ic2 -- 60 ic3 -- 115 ic4 -- 115 ic5 -- 230 ic6 66 -- ic7 -- 230 ic8 -- 115 ic9 -- 230 iv1 -- 229 iv2 120 -- iv3 -- 116 iv4 -- 116 iv5 -- 229 iv6 -- 229 iv7 -- 116 iv8 -- 229 iv9 -- 229 se1 -- 230 * Investigation period was 230 d. ABV, avian bornavirus; dpi, days postinoculation; ic, intracerebrally inoculated; --, not detected or not applicable; iv, intravenously inoculated; se, sentinel. ([dagger]) Antibodies detected by use of indirect immunofluorescence assay; titers <10.0 are considered negative. ([double dagger]) Avian bornavirus RNA detected by real-time reverse transcription PCR as described by Honkavuori et al. (10); cycle thresholds >36.0 are negative. Table 2. Postmortem findings in cockatiels experimentally infected with ABV * Antibody Dilatation of Euthanized, titer proventriculus Bird Died, dpi dpi ([dagger]) ([double dagger]) ic1 10,240 2 ic2 - 206 5,120 3 ic3 - 60 20,480 1 ic4 - 115 20,480 0 ic5 - 115 20,480 0 ic6 - 230 5,120 0 ic7 66 - 1,0240 0 ic8 - 230 1,0240 0 ic9 - 115 5,120 0 iv1 - 230 10,240 2 iv2 - 229 5,120 2 iv3 120 - 10,240 2 iv4 - 116 5,120 1 iv5 - 116 20,480 0 iv6 - 229 10,240 0 iv7 - 229 10,240 0 iv8 - 116 5,120 0 iv9 - 229 20,480 0 se1 - 229 <10 0 Antigen detection ([section]) Infectious virus Bird p14 p24 ([paragraph]) ic1 + + + ic2 + + + ic3 + + + ic4 + + + ic5 + + + ic6 + + + ic7 + + + ic8 + + + ic9 + + + iv1 + + + iv2 + + + iv3 + - + iv4 + + + iv5 + + + iv6 + + + iv7 + + + iv8 + + + iv9 + + + se1 - - - * Proventricular dilatation disease was confirmed in all birds by histopathologic confirmation of lymphoplasmacytic infiltrates of/near ganglia in the central nervous system and/or upper gastrointestinal tract. ABV, avian bornavirus; dpi, days postinoculation; ic, intracerebrally inoculated; +, positive; -, negative; iv, intravenously inoculated; se, sentinel. ([dagger]) Antibodies against avian bornavirus detected by use of indirect immunofluorescence assay; titers <10.0 are considered negative. ([double dagger]) 0, no dilatation; 1, mild dilatation; 2, moderate dilatation; 3, severe dilatation. ([section]) Detection of the X-protein (p14) and the phosphoprotein (p24) of Borna disease virus by immunohistochemical testing. ([paragraph]) Re-isolation of infectious ABV in quail cell line CEC-32.
|Printer friendly Cite/link Email Feedback|
|Author:||Piepenbring, Anne K.; Enderlein, Dirk; Herzog, Sibylle; Kaleta, Erhard F.; Heffels-Redmann, Ursula;|
|Publication:||Emerging Infectious Diseases|
|Article Type:||Clinical report|
|Date:||Feb 1, 2012|
|Previous Article:||Declining Guillain-Barre Syndrome after campylobacteriosis control, New Zealand, 1988-2010.|
|Next Article:||Effect of surveillance method on reported characteristics of Lyme disease, Connecticut, 1996-2007.|